(Q54268449)

27 May 2018

title

Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis. (English)

1 reference

27 May 2018

non-alcoholic steatohepatitis

main subject

steatohepatitis

0 references

0 references

author

Vicente Arroyo

10

1 reference

27 May 2018

Joan Clària

11

1 reference

27 May 2018

author name string

Cristina López-Vicario

1

1 reference

27 May 2018

Ana González-Périz

2

1 reference

27 May 2018

Bibiana Rius

3

1 reference

27 May 2018

Eva Morán-Salvador

4

1 reference

27 May 2018

Verónica García-Alonso

5

1 reference

27 May 2018

Juan José Lozano

6

1 reference

27 May 2018

Ramón Bataller

7

1 reference

27 May 2018

Montserrat Cofán

8

1 reference

27 May 2018

Jing X Kang

9

1 reference

27 May 2018

Esther Titos

12

1 reference

27 May 2018

language of work or name

English

0 references

publication date

14 March 2013

1 reference

27 May 2018

published in

Gut

1 reference

27 May 2018

volume

63

1 reference

27 May 2018

issue

2

1 reference

27 May 2018

page(s)

344-355

1 reference

27 May 2018

Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease

cites work

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Mechanisms of disease progression in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Obesity, Inflammation, and Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Gene ontology: tool for the unification of biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

A human hepatocellular in vitro model to investigate steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Rat liver slices as a tool to study LPS-induced inflammatory response in the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Identification and characterization of a novel delta6/delta5 fatty acid desaturase inhibitor as a potential anti-inflammatory agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Palmitoleate is a mitogen, formed upon stimulation with growth factors, and converted to palmitoleoyl-phosphatidylinositol

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

JNK regulation of hepatic manifestations of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

The opposing effects of n-3 and n-6 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Polyunsaturated fatty acid synthesis: what will they think of next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

The plasma lipidomic signature of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Fat-1 transgenic mice: a new model for omega-3 research

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Transgenic expression of n-3 fatty acid desaturase (fat-1) in C57/BL6 mice: Effects on glucose homeostasis and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

The fat-1 transgene in mice increases antioxidant potential, reduces pro-inflammatory cytokine levels, and enhances PPAR-gamma and SIRT-1 expression on a calorie restricted diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Complex I-associated hydrogen peroxide production is decreased and electron transport chain enzyme activities are altered in n-3 enriched fat-1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Omega 3 - Omega 6: What is right for the liver?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Elovl6 promotes nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

Fat-1 mice convert n-6 to n-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303179

10.1136/GUTJNL-2012-303179

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018